JP2002363097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002363097A5 JP2002363097A5 JP2001312701A JP2001312701A JP2002363097A5 JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5 JP 2001312701 A JP2001312701 A JP 2001312701A JP 2001312701 A JP2001312701 A JP 2001312701A JP 2002363097 A5 JP2002363097 A5 JP 2002363097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- pharmaceutically acceptable
- stabilizer
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 10
- 239000003381 stabilizer Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 0 CC(CC(N(C*1=C)C(C)C1O)=O)C(*)CC(N)O Chemical compound CC(CC(N(C*1=C)C(C)C1O)=O)C(*)CC(N)O 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001312701A JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11-187713 | 1999-07-01 | ||
| JP1999187713 | 1999-07-01 | ||
| JP18771399 | 1999-07-01 | ||
| JP2001312701A JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Division JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002363097A JP2002363097A (ja) | 2002-12-18 |
| JP2002363097A5 true JP2002363097A5 (enExample) | 2007-06-14 |
| JP4691866B2 JP4691866B2 (ja) | 2011-06-01 |
Family
ID=16210881
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Expired - Lifetime JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
| JP2001312701A Expired - Lifetime JP4691866B2 (ja) | 1999-07-01 | 2001-10-10 | 安定化された凍結乾燥型医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001507492A Expired - Lifetime JP3381722B2 (ja) | 1999-07-01 | 2000-06-29 | 安定化された凍結乾燥型医薬組成物 |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6774104B1 (enExample) |
| EP (1) | EP1107777B1 (enExample) |
| JP (2) | JP3381722B2 (enExample) |
| KR (1) | KR100454784B1 (enExample) |
| CN (2) | CN100352495C (enExample) |
| AR (1) | AR024634A1 (enExample) |
| AT (1) | ATE280583T1 (enExample) |
| AU (1) | AU752265B2 (enExample) |
| BR (2) | BRPI0006823B8 (enExample) |
| CA (1) | CA2341568C (enExample) |
| CZ (1) | CZ295720B6 (enExample) |
| DE (1) | DE60015279T2 (enExample) |
| ES (1) | ES2225161T3 (enExample) |
| HK (1) | HK1040057B (enExample) |
| HU (1) | HU229089B1 (enExample) |
| ID (1) | ID29468A (enExample) |
| IL (2) | IL141455A0 (enExample) |
| MX (1) | MXPA01000601A (enExample) |
| NO (1) | NO330353B1 (enExample) |
| NZ (1) | NZ510290A (enExample) |
| OA (1) | OA11601A (enExample) |
| PL (1) | PL200141B1 (enExample) |
| PT (1) | PT1107777E (enExample) |
| RU (1) | RU2251411C2 (enExample) |
| TR (1) | TR200100609T1 (enExample) |
| TW (1) | TWI233805B (enExample) |
| WO (1) | WO2001002002A1 (enExample) |
| ZA (1) | ZA200101589B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| ITMI20021040A1 (it) * | 2002-05-16 | 2003-11-17 | Novuspharma Spa | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale |
| EP1525884B1 (en) | 2002-07-31 | 2011-10-12 | Senju Pharmaceutical Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| US8877168B1 (en) | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| AU2003298662A1 (en) * | 2002-11-18 | 2004-06-15 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
| US20060074014A1 (en) * | 2002-11-18 | 2006-04-06 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
| CA2558191C (en) * | 2004-03-04 | 2011-01-04 | Eisai R&D Management Co., Ltd. | Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| US7514450B2 (en) * | 2004-05-19 | 2009-04-07 | Neurosearch A/S | Azabicyclic aryl derivatives |
| EP2417986A1 (en) * | 2004-11-22 | 2012-02-15 | Anadis Ltd. | Bioactive compositions |
| KR101307999B1 (ko) | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
| KR20080028942A (ko) * | 2005-07-20 | 2008-04-02 | 교와 메덱스 가부시키가이샤 | 생체 시료 중의 펩티드의 안정화 방법 |
| CN1962852B (zh) * | 2006-11-27 | 2011-11-09 | 西北农林科技大学 | 红景天多糖在制备抗冻剂中的新用途及其产品和制备方法 |
| CN102614491B (zh) * | 2011-01-31 | 2014-04-16 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途 |
| CN102614492B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物 |
| CN104968348B (zh) * | 2012-05-22 | 2018-04-17 | Paion英国有限公司 | 包含短效苯二氮杂*类化合物的组合物 |
| US20140274994A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Stabilizing ceftolozane |
| US20140274993A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane-tazobactam pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| CN103330933B (zh) * | 2013-04-26 | 2015-08-05 | 江苏豪森药业股份有限公司 | 含有米卡芬净或其盐的药物组合物 |
| CN103330932B (zh) * | 2013-04-26 | 2015-12-23 | 江苏豪森药业股份有限公司 | 一种米卡芬净或其盐的药物组合物 |
| ES2978920T3 (es) * | 2013-06-05 | 2024-09-23 | Univ British Columbia | Compuestos antifibrogénicos, métodos y usos de los mismos |
| US10376496B2 (en) | 2013-09-09 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| KR101611349B1 (ko) | 2014-04-14 | 2016-04-12 | 신우철 | 안정성이 개선된 밀크씨슬 엑스의 제형 |
| JP7109189B2 (ja) * | 2014-05-29 | 2022-07-29 | シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッド | シクロペプチド系化合物の組成物およびその製造方法と使用 |
| RU2732129C2 (ru) * | 2014-12-05 | 2020-09-11 | Мейдзи Сейка Фарма Ко., Лтд. | Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата |
| DK3240529T3 (da) * | 2014-12-31 | 2022-02-28 | Galenicum Health S L U | Stabile farmaceutiske sammensætninger omfattende micafungin |
| PL3058958T3 (pl) | 2015-02-23 | 2019-02-28 | Selectchemie Ag | Kompozycja anidulafunginy |
| AU2017376960B2 (en) | 2016-12-16 | 2023-12-14 | Baxter Healthcare Sa | Micafungin compositions |
| US11185527B2 (en) | 2017-06-26 | 2021-11-30 | Wayne State University | Methods and compositions relating to steroid hormone receptor-dependent cancers |
| RU2666148C1 (ru) * | 2017-10-05 | 2018-09-06 | Общество с ограниченной ответственностью "Новые Антибиотики" | Способ получения водорастворимой лиофилизированной формы соли бис(2-тио-4,6-диоксо-1,2,3,4,5,6-гексагидропиримидин-5-ил)-(4-нитрофенил)метана |
| EP3485873A1 (en) | 2017-11-17 | 2019-05-22 | Cadila Healthcare Limited | Stable pharmaceutical injectable compositions of micafungin |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03193735A (ja) | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
| JPH03240727A (ja) | 1990-02-15 | 1991-10-28 | Toyo Jozo Co Ltd | ニューモシスチス・カリニ肺炎治療剤 |
| IE912046A1 (en) * | 1990-06-18 | 1991-12-18 | Fujisawa Pharmaceutical Co | New polypeptide compound and a process for preparation¹thereof |
| JP3193735B2 (ja) | 1991-07-24 | 2001-07-30 | 株式会社リコー | カラー画像形成装置の搬送装置 |
| RU2095081C1 (ru) * | 1991-12-13 | 1997-11-10 | Акционерное общество "Биофа" | Фармацевтическая композиция антивирусного действия |
| JPH0651641A (ja) | 1992-07-30 | 1994-02-25 | Olympus Optical Co Ltd | 湿式現像装置 |
| JPH06172204A (ja) * | 1992-12-09 | 1994-06-21 | Asahi Chem Ind Co Ltd | アクレアシン類含有リポソーム製剤およびその製造法 |
| JP3240727B2 (ja) | 1993-02-25 | 2001-12-25 | ソニー株式会社 | 偏平型陰極線管の画像歪補正装置 |
| US6268338B1 (en) * | 1993-04-30 | 2001-07-31 | Merck & Co., Inc. | Cyclohexapeptidyl amine compounds |
| AU681119B2 (en) * | 1993-05-17 | 1997-08-21 | Fujisawa Pharmaceutical Co., Ltd. | New polypeptide compound and a process for preparation thereof |
| WO1996011210A1 (en) * | 1994-10-07 | 1996-04-18 | Fujisawa Pharmaceutical Co., Ltd. | Cyclic hexapeptides having antibiotic activity |
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
| US6245349B1 (en) * | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
| DE69739532D1 (de) * | 1996-03-08 | 2009-09-24 | Astellas Pharma Inc | Prozess für die deacylierung von zyklischen lipopeptiden. |
| AR006598A1 (es) * | 1996-04-19 | 1999-09-08 | Merck Sharp & Dohme | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" |
| JPH09301997A (ja) | 1996-05-17 | 1997-11-25 | Yamanouchi Pharmaceut Co Ltd | 新規環状ペプチド系化合物 |
| FR2755857B1 (fr) * | 1996-11-19 | 1998-12-24 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
| AUPO371596A0 (en) * | 1996-11-19 | 1996-12-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AUPO381496A0 (en) * | 1996-11-25 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| JPH10279498A (ja) * | 1997-04-07 | 1998-10-20 | Nippon Shinyaku Co Ltd | 慢性関節リウマチ治療剤 |
| JP3544847B2 (ja) * | 1998-01-16 | 2004-07-21 | 三菱電機株式会社 | 光学的情報再生方法および装置 |
| DK1582204T3 (da) * | 1999-03-03 | 2013-11-04 | Lilly Co Eli | Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer |
| IL145188A0 (en) * | 1999-03-03 | 2002-06-30 | Lilly Co Eli | Processes for making pharmaceutical oral ecb formulations and compositions |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
-
2000
- 2000-06-28 TW TW089112754A patent/TWI233805B/zh not_active IP Right Cessation
- 2000-06-29 PL PL346297A patent/PL200141B1/pl unknown
- 2000-06-29 WO PCT/JP2000/004381 patent/WO2001002002A1/en not_active Ceased
- 2000-06-29 BR BRPI0006823A patent/BRPI0006823B8/pt unknown
- 2000-06-29 JP JP2001507492A patent/JP3381722B2/ja not_active Expired - Lifetime
- 2000-06-29 RU RU2001108569/15A patent/RU2251411C2/ru active
- 2000-06-29 CA CA2341568A patent/CA2341568C/en not_active Expired - Lifetime
- 2000-06-29 TR TR2001/00609T patent/TR200100609T1/xx unknown
- 2000-06-29 CZ CZ20011186A patent/CZ295720B6/cs not_active IP Right Cessation
- 2000-06-29 IL IL14145500A patent/IL141455A0/xx active IP Right Grant
- 2000-06-29 DE DE60015279T patent/DE60015279T2/de not_active Expired - Lifetime
- 2000-06-29 OA OA1200100048A patent/OA11601A/en unknown
- 2000-06-29 MX MXPA01000601A patent/MXPA01000601A/es active IP Right Grant
- 2000-06-29 EP EP00940916A patent/EP1107777B1/en not_active Expired - Lifetime
- 2000-06-29 CN CNB2004100880760A patent/CN100352495C/zh not_active Expired - Lifetime
- 2000-06-29 AT AT00940916T patent/ATE280583T1/de active
- 2000-06-29 ID IDW20010749A patent/ID29468A/id unknown
- 2000-06-29 HU HU0103740A patent/HU229089B1/hu unknown
- 2000-06-29 NZ NZ510290A patent/NZ510290A/en not_active IP Right Cessation
- 2000-06-29 KR KR10-2001-7002318A patent/KR100454784B1/ko not_active Expired - Lifetime
- 2000-06-29 BR BR0006823-3A patent/BR0006823A/pt not_active IP Right Cessation
- 2000-06-29 PT PT00940916T patent/PT1107777E/pt unknown
- 2000-06-29 US US09/786,125 patent/US6774104B1/en not_active Expired - Lifetime
- 2000-06-29 ES ES00940916T patent/ES2225161T3/es not_active Expired - Lifetime
- 2000-06-29 HK HK02101689.2A patent/HK1040057B/zh not_active IP Right Cessation
- 2000-06-29 CN CNB008012164A patent/CN1179748C/zh not_active Expired - Lifetime
- 2000-06-29 AU AU55722/00A patent/AU752265B2/en not_active Expired
- 2000-06-30 AR ARP000103372A patent/AR024634A1/es not_active Application Discontinuation
-
2001
- 2001-02-15 IL IL141455A patent/IL141455A/en not_active IP Right Cessation
- 2001-02-22 NO NO20010893A patent/NO330353B1/no not_active IP Right Cessation
- 2001-02-26 ZA ZA200101589A patent/ZA200101589B/en unknown
- 2001-10-10 JP JP2001312701A patent/JP4691866B2/ja not_active Expired - Lifetime
-
2004
- 2004-02-06 US US10/772,281 patent/US7112565B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002363097A5 (enExample) | ||
| RU2001108569A (ru) | Стабилизированная фармацевтическая композиция в лиофилизированной форме | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| CA2341568A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
| CA2288143A1 (en) | Activated protein c formulations | |
| JP2003506416A5 (enExample) | ||
| JP2006516648A5 (enExample) | ||
| JP2004509061A5 (enExample) | ||
| JP2004504406A5 (enExample) | ||
| JP2010523714A5 (enExample) | ||
| JPWO2019107530A1 (ja) | 炎症性腸疾患の治療薬 | |
| KR100546450B1 (ko) | 약학 조성물 | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| KR20220081311A (ko) | 니클로사마이드를 포함하는 근육내 및/또는 피하 투여용 약학적 조성물 | |
| JP2002509154A5 (enExample) | ||
| JP4752987B2 (ja) | 外用剤組成物 | |
| JP2001261578A (ja) | 眼科用組成物 | |
| JP2002080490A (ja) | 新規ヌクレオシド | |
| US5925625A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| JP2001322936A (ja) | 眼科用組成物 | |
| US10308937B2 (en) | Combination long acting compositions and methods for Hepatitis C | |
| US20170333460A1 (en) | Long acting pharmaceutical compositions for hepatitis c | |
| WO2003026570A3 (en) | Reduced toxicity cisplatin formulations and methods for using the same | |
| JP5514270B2 (ja) | アシタザノラスト含有組成物 | |
| JPH0678241B2 (ja) | ｔＰＡ医薬組成物 |